BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34052342)

  • 21. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
    Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
    Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heuristic knowledge-based planning for single-isocenter stereotactic radiosurgery to multiple brain metastases.
    Ziemer BP; Sanghvi P; Hattangadi-Gluth J; Moore KL
    Med Phys; 2017 Oct; 44(10):5001-5009. PubMed ID: 28731267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetric study of different radiotherapy planning approaches for hippocampal avoidance whole-brain radiation therapy (HA-WBRT) based on fused CT and MRI imaging.
    Wang BH; Hua W; Gu X; Wang XL; Li J; Liu LQ; Huang YX
    Australas Phys Eng Sci Med; 2015 Dec; 38(4):767-75. PubMed ID: 26577714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal sparing approach in fractionated stereotactic brain VMAT radio therapy: A retrospective feasibility analysis.
    Daniela Falco M; Giancaterino S; D'Andrea M; Gimenez De Lorenzo R; Trignani M; Caravatta L; Di Carlo C; Di Biase S; Allajbej A; Genovesi D
    J Appl Clin Med Phys; 2018 Jan; 19(1):86-93. PubMed ID: 29125239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
    Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
    Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
    BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation dose and incidence of new metastasis in the anterior temporal lobe structures of radiosurgically treated patients.
    Basina BR; Olson C; Roy DK; Yen CP; Schlesinger D; Nagayama K; Sheehan JP
    J Neurosurg; 2010 Jan; 112(1):122-9. PubMed ID: 19499979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases.
    Jiang A; Sun W; Zhao F; Wu Z; Shang D; Yu Q; Wang S; Zhu J; Yang F; Yuan S
    Radiat Oncol; 2019 Mar; 14(1):46. PubMed ID: 30876444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.
    Park HS; Wang EH; Rutter CE; Corso CD; Chiang VL; Yu JB
    J Neurosurg; 2016 Apr; 124(4):1018-24. PubMed ID: 26473783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar AK; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):452-64. PubMed ID: 12957257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
    Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
    Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perihippocampal failure after hippocampal-avoidance whole-brain radiotherapy in cancer patients with brain metastases: Results of a retrospective analysis.
    Shieh LT; Lee SW; Chen CC; Ho YC; Wang YW; Ho SY
    Medicine (Baltimore); 2022 Apr; 101(14):e29144. PubMed ID: 35446298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.
    Shultz DB; Modlin LA; Jayachandran P; Von Eyben R; Gibbs IC; Choi CYH; Chang SD; Harsh GR; Li G; Adler JR; Hancock SL; Soltys SG
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):993-999. PubMed ID: 26194677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.